A Randomized Phase 2 Trial of Combining Sipuleucel-T With Immediate vs. Delayed CTLA-4 Blockade for Prostate Cancer

Clinical Trial ID NCT01804465

PubWeight™ 22.12^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01804465

Top papers